{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "6335723", "DateCompleted": {"Year": "1985", "Month": "05", "Day": "15"}, "DateRevised": {"Year": "2024", "Month": "01", "Day": "09"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0386-846X", "JournalIssue": {"Volume": "7", "Issue": "11", "PubDate": {"Year": "1984", "Month": "Nov"}}, "Title": "Journal of pharmacobio-dynamics", "ISOAbbreviation": "J Pharmacobiodyn"}, "ArticleTitle": "Pharmacological studies on ginger. I. Pharmacological actions of pungent constitutents, (6)-gingerol and (6)-shogaol.", "Pagination": {"StartPage": "836", "EndPage": "848", "MedlinePgn": "836-48"}, "Abstract": {"AbstractText": ["General pharmacological studies were performed on (6)-gingerol and (6)-shogaol which are the pungent constituents of ginger (Zingiber officinale Roscoe). Intravenous (i.v.) administration of (6)-gingerol (at 1.75-3.5 mg/kg) or (6)-shogaol (at 1.75-3.5 mg/kg) and oral administration of them (at 70-140 mg/kg) produced an inhibition of spontaneous motor activity, an antipyretic and analgesic effects, prolonged hexobarbital-induced sleeping time, and these effects of (6)-shogaol were mostly more intensive than that of (6)-gingerol. (6)-Shogaol showed an intense antitussive effect in comparison with dihydrocodeine phosphate. In the electro-encephalogram of cortex, the low amplitude fast wave pattern was observed for 5 min after i.v. administration of (6)-shogaol, and then changed to the drowsy pattern, which was restored after 60 min. In the gastro-intestinal system, (6)-shogaol intensively inhibited the traverse of charcoal meal through the intestine in contrast with (6)-gingerol after i.v. administration of 3.5 mg/kg, but (6)-shogaol facilitated such an intestinal function after oral administration of 35 mg/kg. Both (6)-shogaol and (6)-gingerol suppressed gastric contraction in situ, and the suppression by the former was more intensive than that by the latter. In the cardiovascular system, both (6)-shogaol and (6)-gingerol produced depressor response at lower doses on the blood pressure. At high doses, both drugs produced three phase pattern."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Suekawa", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ishige", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Yuasa", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Sudo", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Aburada", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Hosoya", "ForeName": "E", "Initials": "E"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "J Pharmacobiodyn", "NlmUniqueID": "7901854", "ISSNLinking": "0386-846X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Analgesics"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"}, {"RegistryNumber": "0", "NameOfSubstance": "Anticonvulsants"}, {"RegistryNumber": "0", "NameOfSubstance": "Catechols"}, {"RegistryNumber": "0", "NameOfSubstance": "Fatty Alcohols"}, {"RegistryNumber": "83DNB5FIRF", "NameOfSubstance": "shogaol"}, {"RegistryNumber": "925QK2Z900", "NameOfSubstance": "gingerol"}, {"RegistryNumber": "AL8Z8K3P6S", "NameOfSubstance": "Hexobarbital"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Analgesics"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"}, {"QualifierName": [], "DescriptorName": "Anticonvulsants"}, {"QualifierName": ["pharmacology", "toxicity"], "DescriptorName": "Catechols"}, {"QualifierName": ["analysis"], "DescriptorName": "Condiments"}, {"QualifierName": [], "DescriptorName": "Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Electroencephalography"}, {"QualifierName": ["pharmacology", "toxicity"], "DescriptorName": "Fatty Alcohols"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gastrointestinal Motility"}, {"QualifierName": [], "DescriptorName": "Guinea Pigs"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hemodynamics"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Hexobarbital"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": [], "DescriptorName": "Injections, Intravenous"}, {"QualifierName": ["drug effects"], "DescriptorName": "Intestinal Absorption"}, {"QualifierName": [], "DescriptorName": "Lethal Dose 50"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["drug effects"], "DescriptorName": "Motor Activity"}, {"QualifierName": ["drug effects"], "DescriptorName": "Muscle Tonus"}, {"QualifierName": ["analysis"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rabbits"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["drug effects"], "DescriptorName": "Sleep"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1984", "Month": "11", "Day": "1"}, {"Year": "1984", "Month": "11", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1984", "Month": "11", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["6335723", "10.1248/bpb1978.7.836"]}}]}